Evidence map›Paper›PMID 34741569›Full record

ArticlePediatric diabetes2021

Telemedicine and COVID-19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world-wide cross-sectional web-based survey.

Elisa Giani, Klemen Dovc, Tiago Jeronimo Dos Santos, Agata Chobot, Katarina Braune, Roque Cardona-Hernandez, Carine De Beaufort, Andrea E Scaramuzza, ISPAD Jenious Group

Abstract read
In one paragraph

Article in Pediatric diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Pandemic COVID-19 as a challenge for telemedicine in the Czech Republic.The International journal of health planning and management · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Review
  17. Smartphone, Vestibular Hypofunction, Teleconsultation and COVID-19 Pandemic.International archives of otorhinolaryngology · 2022
    Article
  18. Telemedicine and diabetes during the COVID-19 era.Archives of medical sciences. Atherosclerotic diseases · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elisa GianiDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.ORCID 0000-0001-7806-9241
Klemen DovcDepartment of Pediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, Ljubljana, Slovenia, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.ORCID 0000-0001-9201-2145
Tiago Jeronimo Dos SantosPediatric Unit, Vithas Almería, Instituto Hispalense de Pediatría, Almería, Spain.
Agata ChobotDepartment of Pediatrics, Institute of Medical Sciences, University of Opole, Opole, Poland.ORCID 0000-0002-9622-4433
Katarina BrauneDepartment of Pediatric Endocrinology and Diabetes, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Roque Cardona-HernandezDivision of Pediatric Endocrinology, Hospital Sant Joan de Déu, Barcelona, Spain.
Carine De BeaufortDECCP, Clinique Pédiatrique/CH de Luxembourg, Luxembourg, GD de, Luxembourg.ORCID 0000-0003-4310-6799
Andrea E ScaramuzzaDivision of Paediatrics, Pediatric Diabetes, Endocrinology and Nutrition, ASST Cremona, Cremona, Italy.ORCID 0000-0002-1518-8515
ISPAD Jenious Group

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundTelemedicine for routine care of people with diabetes (PwD) during the COVID-19 pandemic rapidly increased in many countries, helping to address the several barriers usually seen.

objectiveThis study aimed to describe healthcare professionals' (HCPs) experience on telemedicine use in diabetes care and investigate the changes and challenges associated with its implementation.

methodsA cross-sectional electronic survey was distributed through the global network of JENIOUS members of ISPAD. Respondents' professional and practice profiles, clinic sizes, their country of practice, and data regarding local telemedicine practices during COVID-19 pandemic were investigated.

resultsAnswers from 209 HCPs from 33 countries were analyzed. During the pandemic, the proportion of PwD receiving telemedicine visits increased from <10% (65.1% of responders) to >50% (66.5%). There was an increase in specific privacy requirements for remote visits (37.3% to 75.6%), data protection policies (42.6% to 74.2%) and reimbursement for remote care (from 41.1% to 76.6%). Overall, 83.3% HCPs reported to be satisfied with the use of telemedicine. Some concerns (17.5%) about the complexity and heterogeneity of the digital platforms to be managed in everyday practice remain, feeding the need for unifying and making interoperable the tools for remote care. Also, 45.5% of professionals reported to feel stressed by the need for extra-time for telemedicine consultations.

conclusionsTelemedicine was rapidly and broadly adopted during the pandemic globally. Some issues related to its use were promptly addressed by local institutions. Challenges with the use of different platforms and for the need of extra-time still remain to be solved.

Indexed as

TelemedicineAdultAgedAged, 80 and overCOVID-19Cross-Sectional StudiesDiabetes MellitusFemaleHealth PersonnelHumansInternationalityInternetMaleMiddle AgedPandemicsPrivacyCOVID-19pediatricstelehealthtelemedicinetype 1 diabetesvirtual

Identifiers

PMID34741569
PMCPMC8661953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.